Immunocore shareholders re-elect all directors, approve executive compensation, ratify Deloitte at 2024 AGM

Immunocore Holdings plc

Bahija Jallal re-elected with 34.24M for (99.96%); Sir John Bell re-elected with 30.13M for (87.95%).
Advisory say-on-pay passed with 33.62M for (98.07%); shareholders chose 'One Year' frequency (34.21M votes).
Deloitte LLP ratified as U.S. independent auditor for 2024 with 34.26M for (99.99%).
New articles of association adopted as special resolution with 34.25M for (99.99%).
Directors' remuneration report for 2023 approved with 33.72M for (98.44%).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.